16,558 findings · published 2017+
- AdherenceModerate
Structured, ongoing nutritional counseling and education significantly increase weight management nutrition knowledge scores compared to baseline or no counseling.
If you are trying to manage your weight, seek out professional nutritional counseling rather than relying solely on self-education. The study shows that ongoing interaction with a dietitian significantly improves your understanding of weight management principles, which is a key component of long-term success.
Supports 2026New - AdherenceModerate
Time-restricted eating (TRE) with an 8-hour window and ad libitum intake reduces body weight, fat mass, and visceral fat in overweight adults with a baseline eating window ≥14 hours, primarily through reduced eating occasions rather than explicit caloric restriction.
If you currently eat over 14 hours a day, try compressing your eating into an 8-hour window (e.g., 10 am to 6 pm) without changing what or how much you eat. This natural reduction in eating frequency may lead to modest weight and fat loss over 12 weeks.
Supports 2020 - HormonalModerate
Tirzepatide, a dual GIP and GLP-1 receptor agonist, produces substantial, clinically meaningful, and sustained weight reduction in adults with obesity (BMI ≥30 or ≥27 with comorbidities) when used as an adjunct to lifestyle intervention, demonstrating superior efficacy compared to selective GLP-1 receptor agonists.
If you have obesity (BMI ≥30, or ≥27 with health issues like high blood pressure or sleep apnea), tirzepatide is a once-weekly injection that works by mimicking gut hormones (GIP and GLP-1) to help you lose weight. It is used alongside a reduced-calorie diet and exercise. The dose starts low (2.5 mg) and increases every 4 weeks to minimize stomach issues, reaching up to 15 mg. Clinical trials are designed to show it causes more weight loss than older drugs like semaglutide.
Supports 2022 - HormonalModerate
Combination anti-obesity medications (AOMs) are more effective than monotherapy for treating weight regain after bariatric surgery, with patients prescribed three or more AOMs losing significantly more weight than those on one.
If you have regained weight after bariatric surgery, taking just one weight-loss medication may not be enough. This study suggests that using a combination of anti-obesity medications, along with lifestyle changes, leads to significantly greater weight loss than using a single medication. Talk to your doctor about whether a combination approach is right for you, keeping in mind that access and cost can be barriers.
Supports 2022 - MixedModerate
A 4-week low-carbohydrate diet (25% carbs, 45% protein, 30% fat) significantly reduces body weight, BMI, and body fat in obese adults while shifting gut microbiota composition by decreasing Firmicutes and increasing Bacteroidetes.
Adopt a low-carbohydrate diet for 4 weeks, aiming for 25% carbs, 45% protein, and 30% fat. Calculate your daily calories based on your ideal body weight (ideal weight in kg multiplied by 20-25, then by 0.75). Focus on high-protein foods, non-starchy vegetables, and use meal replacements if needed to stay on track. Drink at least 1.8 liters of water daily. This approach has been shown to significantly reduce body weight, BMI, and body fat, while improving gut microbiota diversity.
Supports 2024 - MixedModerate
A medically supervised weight management program combining complete meal replacement (82 kcal/g) with behavioral counseling produces a statistically significant average 5.8% weight loss at 5 years, with 35.2% of participants achieving ≥10% weight loss.
To achieve significant long-term weight loss, you need a structured program that combines a strict initial diet (like meal replacements) with ongoing behavioral support. This study shows that losing 5-10% of your body weight over 5 years is possible without surgery or drugs if you commit to weekly counseling and gradual transition to regular food. The key is not just the diet, but the long-term behavioral support and accountability.
Supports 2018 - HormonalModerate
Long-term treatment with semaglutide 2.4 mg (up to 68 weeks) produces significant weight loss (mean 14.5-14.8%) and improves cardiometabolic biomarkers (blood pressure, HbA1c, LDL, triglycerides) in real-world patients with obesity or overweight.
If you have obesity or overweight with a related health condition, semaglutide 2.4 mg taken once weekly can lead to significant weight loss (around 15% of body weight) and improvements in blood pressure, blood sugar, and cholesterol over a year. This is based on real-world data from thousands of patients, suggesting it works effectively outside of strict clinical trial settings. You must be willing to stay on the medication for at least a year to see these full benefits.
Supports 2025New - MixedModerate
A digitally enabled, time-restricted eating (TRE) program combined with low-carbohydrate intake and behavioral support leads to clinically significant weight loss (mean 9.2%) and improved glycemic control in overweight/obese adults, with effects sustained at 12 months.
If you are overweight or obese, a structured program combining time-restricted eating (like 16:8), lower carbohydrate intake, and regular support from a clinician and peer mentor can lead to significant, sustained weight loss (around 9%) and better blood sugar control over a year. It is important to have professional support to manage the behavioral aspects and ensure safety.
Supports 2024 - HormonalModerate
In overweight or obese adults, tirzepatide produces significantly greater weight loss than semaglutide over a 6-month period, particularly in patients without diabetes.
If you are overweight or obese and considering medication, tirzepatide appears to offer greater weight loss benefits than semaglutide over a 6-month period, especially if you do not have diabetes. However, real-world effectiveness can vary based on adherence and cost, so discuss these factors with your provider.
Supports 2025New - MixedModerate
Individualized Virtual Integrative Medicine (IVIM) protocol combined with tirzepatide results in significant weight loss (mean -52.28 lbs at 52 weeks) and high treatment adherence (99.36% achieving >5% weight loss) compared to standard care models.
If you have obesity (BMI >= 30) and are starting tirzepatide, consider a program that offers flexible dosing and regular telehealth support. This approach allows you to adjust your dose based on side effects and progress, rather than following a rigid schedule. Most patients in this study lost significant weight (over 20 lbs on average at 52 weeks) without needing the highest dose, and compounded versions worked just as well as branded ones. The key is consistent support and personalized adjustments.
Supports 2025New - AdherenceModerate
Skeletal muscle mass can be preserved during significant weight loss induced by incretin-based medications if the patient adheres to a program involving twice-weekly strength training and adequate protein intake (60-90 g/day).
To prevent muscle loss while losing weight with these medications, you must actively train. Perform strength training at least twice a week and ensure you are eating 60-90 grams of protein daily. This combination helps stabilize your muscle mass after the initial months of weight loss.
Qualifies 2025New - MixedModerate
The Adaptive Ketogenic–Mediterranean Protocol (AKMP) significantly improves insulin resistance, remnant cholesterol, and body composition in adults with overweight or obesity over a 14-week period.
Follow a 14-week plan starting with very low carbs (≤20g/day) and high healthy fats (olive oil, fish) to reset insulin sensitivity and burn fat. After 12 weeks, gradually add back carbs (>100g/day) while maintaining a Mediterranean diet structure. Monitor your progress and adjust protein or calories if weight loss stalls.
Supports 2025New - HormonalModerate
Adhering to a low carbohydrate diet (LCD) for six months significantly increases the rate of type 2 diabetes remission compared to control diets, with moderate certainty evidence.
If you have type 2 diabetes, switching to a low carbohydrate diet (less than 130g carbs per day) for six months can significantly increase your chances of reversing the condition. This benefit is most pronounced if you are not currently using insulin, though improvements are still seen in insulin users. Work with your doctor to monitor your progress and adjust medications as needed.
Supports 2021 - HormonalModerate
Low-carbohydrate and ketogenic diets improve glycemic control and reduce body weight in patients with type 2 diabetes, with ketogenic diets showing stronger effects than low-carb diets.
If you have Type 2 Diabetes, reducing carbohydrates (especially to <50g/day for a ketogenic diet) can significantly improve blood sugar control and help with weight loss. This often allows for a reduction in diabetes medication. However, you must be monitored by a healthcare provider, especially if you take SGLT-2 inhibitors, due to the risk of ketoacidosis. Focus on long-term sustainability and individual tolerance.
Supports 2019 - Macro partitioningModerate
Adherence to a very low-carbohydrate diet (VLCD) of approximately 36g carbohydrates per day in individuals with Type 1 Diabetes Mellitus (T1DM) results in exceptional glycemic control (mean HbA1c 5.67%) with low rates of adverse events, including hypoglycemia and diabetic ketoacidosis (DKA).
If you have Type 1 Diabetes, adopting a very low-carbohydrate diet (around 30-40g carbs daily from fibrous vegetables and nuts) can significantly improve your average blood sugar (HbA1c) to near-normal levels. This approach requires careful insulin adjustment, particularly reducing total daily insulin doses, but may result in fewer severe hypoglycemic events and hospitalizations compared to standard high-carbohydrate diets. Consult your healthcare provider to adjust your insulin regimen safely.
Supports 2018 - HormonalModerate
Adopting a low-carbohydrate or ketogenic diet improves glycemic control, promotes weight loss, and reduces medication requirements in patients with type 2 diabetes and obesity.
If you have type 2 diabetes or obesity, reducing carbohydrates (especially to <130g/day, or <50g/day for ketosis) is a valid medical strategy. You must work with your doctor to reduce diabetes medications (especially insulin and sulphonylureas) immediately to avoid low blood sugar. Focus on eating until you are full rather than counting calories, as this diet naturally reduces hunger.
Supports 2020 - MixedModerate
Oral nutritional supplements (ONS) containing high-quality protein and micronutrients are an effective strategy to prevent nutrient deficiencies and support muscle health in patients with reduced appetite from IMDs.
If you can't eat enough protein due to nausea or fullness from your medication, use oral nutritional supplements (ONS) to fill the gap. Choose products specifically designed for muscle health, not just isolated vitamin pills.
Supports 2024 - Energy balanceModerate
Physical activity is a critical factor in successful long-term weight maintenance, likely by mitigating the increased appetite and decreased energy expenditure associated with the weight-reduced state.
Incorporate regular, moderately vigorous to vigorous physical activity into your routine. It helps counteract the biological drive to eat more and the slowdown in metabolism that occurs after weight loss. Focus on consistency rather than intensity.
Supports 2021 - HormonalModerate
Initiating time-restricted eating (≤10h daily window) and high-intensity interval training (HIT) during the preconception period improves maternal insulin sensitivity and glycaemic control, thereby reducing the risk of gestational diabetes and adverse offspring metabolic outcomes.
Start optimizing your metabolic health before you conceive. Adopt a daily eating window of 10 hours or less to improve insulin sensitivity. Incorporate 2-3 short sessions of high-intensity interval training per week (e.g., 4-10 bursts of effort separated by rest). If pregnant, shorten the work bouts to under 60 seconds to ensure fetal safety. Focus on improving insulin sensitivity rather than rapid weight loss.
Supports 2020 - MixedModerate
Multicomponent lifestyle interventions (diet, exercise, and behavioral strategies) are effective for reducing weight, central obesity, and insulin resistance in women with PCOS, with benefits observed even with modest weight loss (5-10%).
Start with a multicomponent approach: combine a modest calorie deficit (500-750 kcal/day) with regular physical activity (150+ minutes/week) and behavioral tracking (e.g., food/exercise logs). Aim for a 5-10% weight loss over 6 months if you have excess weight, but focus on healthy habits regardless of the scale number. Seek support from a dietitian or health psychologist to manage psychological barriers and improve adherence.
Supports 2020 - HormonalModerate
Regular physical activity, including both aerobic and resistance training, improves metabolic and reproductive features in PCOS independent of significant weight loss.
Aim for 150 minutes of moderate activity (like brisk walking) or 75 minutes of vigorous activity per week, plus two days of muscle-strengthening exercises. You don't need to lose weight to see metabolic benefits from exercise. Start with 10-minute bouts and gradually increase duration by 5% each week.
Supports 2020 - MixedModerate
Combined resistance and moderate-intensity aerobic exercise improves functional capacity, muscle strength, and quality of life in post-COVID-19 patients after hospital discharge.
If you are recovering from COVID-19 after hospital discharge, start with a combination of light resistance training (1-2 sets of 8-10 reps at 30-80% of your max) and moderate aerobic exercise (5-30 minutes). Focus on feeling comfortable (RPE 3-5/10) rather than pushing hard. This approach has been shown to improve your ability to walk, your muscle strength, and your overall quality of life without significantly increasing the risk of reinfection.
Supports 2022 - HormonalModerate
High-dose mazdutide (9-10 mg once-weekly) produces robust, statistically significant body weight loss (approx. 10-12%) in Chinese adults with overweight or obesity, with a favorable safety profile despite transient gastrointestinal side effects.
If you are an adult with overweight or obesity, once-weekly injections of mazdutide (9-10 mg) can lead to significant weight loss (around 10%) over 3-4 months. While you may experience temporary stomach issues like nausea or diarrhea, these usually improve over time. This treatment is most effective when combined with maintaining your current diet and exercise habits.
Supports 2022 - Macro partitioningModerate
Consuming 4-5 protein boluses per day, with one near training and one before sleep, optimizes muscle protein synthesis without requiring precise peri-workout carbohydrate timing.
Eat 4-5 meals with protein throughout the day. Make sure one of these meals is within 1-2 hours of your workout and another is within 1-2 hours before you go to sleep. You do not need to rush to consume carbohydrates immediately after training; total daily protein and overall meal distribution are more important.
Supports 2020